Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Yuko Ogata"'
Autor:
Hiroaki Baba, Hajime Kanamori, Issei Seike, Ikumi Niitsuma-Sugaya, Kentaro Takei, Kengo Oshima, Yudai Iwasaki, Yuko Ogata, Hirona Nishimaki, Daisuke Konno, Takuya Shiga, Koji Saito, Koichi Tokuda, Tetsuji Aoyagi
Publikováno v:
Microorganisms, Vol 10, Iss 1, p 19 (2021)
Patients with severe Coronavirus disease 2019 (COVID-19) are at high risk for secondary infection with multidrug-resistant organisms (MDROs). Secondary infections contribute to a more severe clinical course and longer intensive care unit (ICU) stays
Externí odkaz:
https://doaj.org/article/32486dcc17144f9f9f655785b4d31f25
Publikováno v:
eLife, Vol 8 (2019)
DUX4 is a transcription factor whose misexpression in skeletal muscle causes facioscapulohumeral muscular dystrophy (FSHD). DUX4’s transcriptional activity has been extensively characterized, but the DUX4-induced proteome remains undescribed. Here,
Externí odkaz:
https://doaj.org/article/0ef1432bc86143f6b7218ee81a8d4607
Autor:
Minako Ikoma, Soren Gantt, Corey Casper, Yuko Ogata, Qing Zhang, Ryan Basom, Michael R Dyen, Timothy M Rose, Serge Barcy
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0192659 (2018)
Kaposi's sarcoma herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma (KS). Both KSHV and HIV infections are endemic in Uganda, where KS is among the most common cancers in HIV-infected individuals. Recent studies examined the use of small
Externí odkaz:
https://doaj.org/article/275239156e694880a019c5f094c4d12c
Autor:
Samiksha Katiyar, Irina Kufareva, Ranjan Behera, Sarah M Thomas, Yuko Ogata, Michael Pollastri, Ruben Abagyan, Kojo Mensa-Wilmot
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56150 (2013)
Human African trypanosomiasis is caused by the eukaryotic microbe Trypanosoma brucei. To discover new drugs against the disease, one may use drugs in the clinic for other indications whose chemical scaffolds can be optimized via a medicinal chemistry
Externí odkaz:
https://doaj.org/article/e8481334dbb84912b0c2dc73fd99b985
Autor:
Samuel L Hutson, Ernest Mui, Karen Kinsley, William H Witola, Michael S Behnke, Kamal El Bissati, Stephen P Muench, Brittany Rohrman, Susan R Liu, Robert Wollmann, Yuko Ogata, Ali Sarkeshik, John R Yates, Rima McLeod
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e14057 (2010)
Molecular pathways regulating rapid proliferation and persistence are fundamental for pathogens but are not elucidated fully in Toxoplasma gondii. Promoters of T. gondii ribosomal proteins (RPs) were analyzed by EMSAs and ChIP. One RP promoter domain
Externí odkaz:
https://doaj.org/article/974f68e15d6742f48d83dac39db9960b
Autor:
David C Simpson, Edward Kabyemela, Atis Muehlenbachs, Yuko Ogata, Theonest K Mutabingwa, Patrick E Duffy, Michal Fried
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8822 (2010)
Plasmodium falciparum placental malaria (PM) contributes to 10,000 maternal deaths due to severe anemia (SA) each year in Africa, primarily among primigravid women who are most susceptible. Increased levels of proinflammatory cytokines like TNF-alpha
Externí odkaz:
https://doaj.org/article/cab3cbc090bf42cdaeda62edd7e8f891
Autor:
Yusuke Takei, Michio Kumagai, Manami Suzuki, Sakura Mori, Yuna Sato, Toru Tamii, Akane Tamii, Ako Saito, Yuko Ogata, Yu Kaiho, Hiroaki Toyama, Yutaka Ejima, Masanori Yamauchi
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 37:1143-1151
Autor:
Yuko Ogata
Publikováno v:
Journal of Japan Academy of Nursing Science. 41:324-333
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 12; Pages: 3317
Transcatheter aortic valve implantation (TAVI) is an effective treatment for severe aortic stenosis (AS); however, postoperative delirium (POD) can worsen patient outcomes. This study aimed to examine the risk factors for POD after TAVI, including po
Autor:
Jeffrey J. James, Alison J. Gillespie, Yuko Ogata, J. Alaina Floyd, Jeremy M. Shaver, Nancy S. Nightlinger, Richard S. Rogers, Unjy Park, Bruce A. Kerwin
Publikováno v:
Journal of Pharmaceutical Sciences
Formulation screening for biotherapeutics can cover a vast array of excipients and stress conditions. These studies consume quantities of limited material and, with higher concentrated therapeutics, more material is needed. Here, we evaluate the use